Salivary Gland Adenoid Cystic Carcinoma
5 clinical trials · Condition
◉ Watch Salivary Gland Adenoid Cystic Carcinoma
| Record | Firm | Date |
|---|---|---|
| Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma (NCT01604772) | National Cancer Institute (NCI) | 2012-07-23 |
| Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (NCT01175980) | National Cancer Institute (NCI) | 2010-08-06 |
| Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors (NCT00859937) | National Cancer Institute (NCI) | 2009-03-16 |
| Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers (NCT00095563) | National Cancer Institute (NCI) | 2004-09-01 |
| Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck (NCT00077428) | National Cancer Institute (NCI) | 2004-06-01 |
Track Salivary Gland Adenoid Cystic Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.